212 related articles for article (PubMed ID: 6544480)
21. Current opinions in nephrology and hypertension: kidney transplantation in patients with plasma cell dyscrasias.
Lum EL; Bunnapradist S
Curr Opin Nephrol Hypertens; 2019 Nov; 28(6):573-580. PubMed ID: 31403474
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
Ho M; Zanwar S; Buadi FK; Ailawadhi S; Larsen J; Bergsagel L; Binder M; Chanan-Khan A; Dingli D; Dispenzieri A; Fonseca R; Gertz MA; Gonsalves W; Go RS; Hayman S; Kapoor P; Kourelis T; Lacy MQ; Leung N; Lin Y; Muchtar E; Roy V; Sher T; Warsame R; Fonder A; Hobbs M; Hwa YL; Kyle RA; Rajkumar SV; Kumar S
Blood; 2022 Nov; 140(18):1997-2000. PubMed ID: 36096078
[TBL] [Abstract][Full Text] [Related]
23. Polyneuropathies associated with plasma cell dyscrasias.
Kelly JJ
Semin Neurol; 1987 Mar; 7(1):30-9. PubMed ID: 3332445
[No Abstract] [Full Text] [Related]
24. [Neurological manifestations of monoclonal gammopathies].
Chassande B; Léger JM
Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
[TBL] [Abstract][Full Text] [Related]
25. [A case of pure red cell aplasia with monoclonal gammopathy: immune-mediated inhibition of erythropoiesis].
Kobayashi T; Hanada T; Sato Y; Shibuya A; Ninomiya H; Nagasawa T; Abe T
Rinsho Ketsueki; 1987 Nov; 28(11):2029-33. PubMed ID: 3128675
[No Abstract] [Full Text] [Related]
26. Polyneuropathy in paraproteinaemia.
Meier C
J Neurol; 1985; 232(4):204-14. PubMed ID: 2995596
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal gammopathy of uncertain significance.
Alejo E; Puertas B; Mateos MV
Med Clin (Barc); 2023 Sep; 161(5):217-224. PubMed ID: 37330390
[TBL] [Abstract][Full Text] [Related]
28. [Gangrenous pyoderma in monoclonal IgA gammopathy and functional disorders of T lymphocytes].
Samochocki Z; Szudziński A
Przegl Dermatol; 1986; 73(5):409-12. PubMed ID: 3495820
[No Abstract] [Full Text] [Related]
29. Some characteristics of renal injury in plasma cell dyscrasias.
Drazen F; Lenert P; Tepavcević P; Ilić V; Curić S; Uzurov V; Pejin D; Zupunski A; Vodopivec S; Djisalov M
Przegl Lek; 1985; 42(4):372-4. PubMed ID: 4048521
[No Abstract] [Full Text] [Related]
30. Monoclonal gammopathy of undetermined significance versus smoldering myeloma: is active surveillance enough?
Jordan WE; Emmons R; Vogl D; Morris GJ
Semin Oncol; 2011 Jun; 38(3):327-34. PubMed ID: 21600358
[No Abstract] [Full Text] [Related]
31. Monoclonal gammopathies presenting as inflammatory arthritis: uncommon but important--a case series.
Srinivasulu N; Sharma V; Samant R
Int J Rheum Dis; 2012 Jun; 15(3):336-9. PubMed ID: 22709497
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of monoclonal gammopathy of undetermined significance/myeloma in patients with acute osteoporotic vertebral fractures.
Golombick T; Diamond T
Acta Haematol; 2008; 120(2):87-90. PubMed ID: 18852483
[No Abstract] [Full Text] [Related]
33. Neuropathies associated with disorders of plasmocytes.
Noring L; Kjellin KG; Sidén A
Eur Neurol; 1980; 19(4):224-30. PubMed ID: 6249602
[TBL] [Abstract][Full Text] [Related]
34. Successful management of polyneuropathy associated with IgM gammopathy of undetermined significance with antibody-based immunoadsorption.
Toepfer M; Schroeder M; Müller-Felber W; Lochmüller H; Sitter T; Pongratz D; Schiffl H
Clin Nephrol; 2000 May; 53(5):404-7. PubMed ID: 11305816
[TBL] [Abstract][Full Text] [Related]
35. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
36. The promise and harms of screening for plasma cell dyscrasias.
Mohyuddin GR; Chakraborty R; Cliff ERS
Br J Haematol; 2023 Mar; 200(6):704-707. PubMed ID: 36626939
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
[TBL] [Abstract][Full Text] [Related]
38. [Polyneuropathy and monoclonal IgG/IgA gammopathy--differential neurography on the basis of two patient cases].
Abler B; Gdynia HJ; von Arnim CA
Fortschr Neurol Psychiatr; 2009 Feb; 77(2):105-9. PubMed ID: 19221974
[TBL] [Abstract][Full Text] [Related]
39. Unusual association of multiple sclerosis with monoclonal gammopathy of undetermined significance (MGUS): two case reports.
Rentzos M; Michalopoulou M; Gotosidis K; Caponi A; Bonakis A; Kilidireas K; Nikolaou C
Funct Neurol; 2004; 19(4):253-6. PubMed ID: 15776794
[TBL] [Abstract][Full Text] [Related]
40. Benign monoclonal gammopathy presenting with severe renal failure.
Gavarotti P; Fortina F; Costa D; Verzetti G; Redoglia V; Boccadoro M
Scand J Haematol; 1986 Jan; 36(1):115-7. PubMed ID: 3081994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
